iiinova — where your digital self keeps evolving

abnlab.bsky.social @abnlab.bsky.social · 01/05/2026

Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,650. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324!

000

abnlab.bsky.social @abnlab.bsky.social · 17/04/2026

Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,675. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324

010

abnlab.bsky.social @abnlab.bsky.social · 10/04/2026

Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,850. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324!

000

abnlab.bsky.social @abnlab.bsky.social · 27/03/2026

020

abnlab.bsky.social @abnlab.bsky.social · 13/03/2026

010

abnlab.bsky.social @abnlab.bsky.social · 06/03/2026

010

abnlab.bsky.social @abnlab.bsky.social · 30/01/2026

010

abnlab.bsky.social @abnlab.bsky.social · 23/01/2026

010

abnlab.bsky.social @abnlab.bsky.social · 14/01/2026

010

abnlab.bsky.social @abnlab.bsky.social · 14/11/2025

010

abnlab.bsky.social @abnlab.bsky.social · 26/09/2025

Interested in research? Our team is currently seeking healthy volunteers age 18-60 for a psychedelic clinical trial located in New Haven, CT. Participants are eligible for compensation up to $625. If interested, please call us back at 203-974-7324!

010

abnlab.bsky.social @abnlab.bsky.social · 15/09/2025

Our team is currently seeking healthy volunteers age 18-60 for a psychedelic clinical trial located in New Haven, CT. Participants are eligible for compensation up to $625. If interested, please call us back at 203-974-7324!

010

abnlab.bsky.social @abnlab.bsky.social · 24/04/2025

Yale ABNLab will be presenting at SOBP 2025 in Toronto this week! Please see below for more details! #Neuroscience #NeuroPsych #PsychResearch #2025SOBP

020

abnlab.bsky.social @abnlab.bsky.social · 28/02/2025

Read our latest #research on the contribution of #psychotherapy to #psychedelic treatment for #opioid #addiction, published with @SpringerNature in Current Addiction Reports. Read here: rdcu.be/eaAo9

020

abnlab.bsky.social @abnlab.bsky.social · 21/02/2025

Read our latest #research on the contribution of #psychotherapy to #psychedelic treatment for #opioid #addiction, published with @springernature.com in Current Addiction Reports. Read here: rdcu.be/eaAo9

020

Reposted by @abnlab.bsky.social

Anahita Bassir Nia @anahitabn.bsky.social · 07/12/2024

Heading to #acnp2024 to present my research on the #endocannabinoid system in #opioid use disorder. @abnlab.bsky.social @acnporg.bsky.social #acnp2024

041

Reposted by @abnlab.bsky.social

Anahita Bassir Nia @anahitabn.bsky.social · 08/12/2024

A pre #acnp2024 #hike in #Sedona. I hiked #cathedralrock, #littlehorse, and #chapeltrail. I had underestimated #arizona sun! But the trails were wonderful! @acnporg.bsky.social @abnlab.bsky.social

0332

Reposted by @abnlab.bsky.social

Anahita Bassir Nia @anahitabn.bsky.social · 10/12/2024

Another poster from @abnlab.bsky.social with @harpaz-rotem.bsky.social on #cannabinoid receptor type 1 availability in #ptsd with #childhood_trauma today at 5pm. #acnp2024 @acnporg.bsky.social

021

abnlab.bsky.social @abnlab.bsky.social · 06/12/2024

ABN Lab's Dr. Anahita Bassir Nia will be presenting the results of her NIDA-funded study on CB1R availability in opioid use disorder this upcoming Monday, December 9th at #ACNP2024!

010